«

»

Nov 29

An analysis of a Canadian registry of patients with atrial fibrillation

An analysis of a Canadian registry of patients with atrial fibrillation revealed that one in five treated with oral anticoagulants were also treated with antiplatelet medication and that a “substantial proportion” of patients treated with the dual therapy did not have a compelling reason for adding the antiplatelet drug. The findings were presented at the American Heart Association (AHA) 2014 Scientific Sessions.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>